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Introduction
Atypical hemolytic-uremic syndrome (HUS) is defined
by the presence of microangiopathic hemolytic anemia,
acute renal failure, and thrombocytopenia without a
diarrheal prodrome. It is responsible for only ten per-
cent of cases in children. The role of genetic deficiencies
of complement regulation, Von Willebrand factor
cleaving protease (ADAMTS 13), and intracellular
defects of vitamin B12 metabolism has been known in
pathogenesis of disease. Antiphospholipid antibodies
(aPLs) are autoantibodies against negatively charged
phospholipids or phospholipid binding plasma proteins. It
is clear that their presence is associated with thrombosis,
pregnancy morbidity, hematologic, skin, neurological
conditions, and microangiopathy.
Objectives
To our knowledge, there are only two pediatric case series
that showed a high frequency of anticardiolipin antibodies
in children with typical HUS. Microangiopathic antipho-
spholipid-associated syndrome (MAPS) was also described
in a child with atypical HUS.
Herein we reported a 5.5-year-old boy who was
presented with atypical HUS associated with antipho-
spholipid antibodies and antiphospholipid syndrome in
his father.
Methods
A 5.5-year-old boy from Azerbaijan was referred to Mofid
Children’s Hospital, because of edema, hypertension, ane-
mia and acute renal failure. He was healthy until 4 weeks
before admission while he had fever and sore throat. Then
generalized edema, echymosis, gross hematuria and sever
paleness occurred. The history of diarrhea was negative.
On presentation, he was ill, pale but afebrile.
Results
His laboratory data on admission were as following:
white blood cell (WBC): 18800/µL, hemoglobin (Hb):
11g/dl, lactate dehydrogenase (LDH): 6286 Iu/ml, creatin
phosphokinase (CK): 1039 u/L, Erythrocyte sedimentation
rate (ESR): 40 hr, C-reactive protein (CRP): 11 mg/L,
blood urea nitrogen (BUN): 98 mg/dl, creatinin: 3.7 mg/dl,
uric acid: 16.8 mg/dl, Aspartate transaminase (AST):
298 Iu/L , Alanine transaminase (ALT): 37Iu/L. His urina-
lysis showed hematuria (many RBC) and proteinuria (2+).
He had low level of C3: 30 mg/dl (normal range: 90-180)
and his C4 level was 11(10-40) mg/dl.
Conclusion
On the basis of microangiopathic hemolytic anemia,
thrombocytopenia and acute renal failure, he was diag-
nosed as having atypical HUS. To our knowledge, in the
literature, there is no report of this association between
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